Stay updated on Velaglucerase Alfa for Type 1 Gaucher Clinical Trial

Sign up to get notified when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.0, adding details about a study with 32 locations and the intervention drug velaglucerase alfa, while the previous version 2.9.7 has been removed.
    Difference
    2%
    Check dated 2024-07-23T15:20:04.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7, replacing the previous version v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:42:32.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T14:20:20.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the version of the content on the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T10:17:13.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the web page.
    Difference
    0.1%
    Check dated 2024-06-26T09:16:52.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Show more Revision: v2.9.0' has been updated to 'Show less MedlinePlus Genetics related topics: Gaucher disease MedlinePlus related topics: Gaucher Disease Genetic and Rare Diseases Information Center resources: Gaucher Disease Gaucher Disease Type 1 Sphingolipidosis Drug Information available for: Velaglucerase alfa Expanded Access Navigator Expanded Access (Compassionate Use) FDA Drug and Device Resources Show less Keywords Provided by Takeda (Shire) VPRIV Enzyme Replacement Therapy Gaucher disease glucocerebrosidase beta-glucocerebrosidase Acid beta-glucocerebrosidase glucosylceramidase D-glucosyl-N-acylsphingosine glucohydrolase gene activation human Additional Relevant MeSH Terms Sphingolipidoses Lysosomal Storage Diseases, Nervous System Brain Diseases, Metabolic, Inborn Brain Diseases, Metabolic Brain Diseases Central Nervous System Diseases Nervous System Diseases Metabolism, Inborn Errors Genetic Diseases, Inborn Lipidoses Lipid Metabolism, Inborn Errors Lysosomal Storage Diseases Metabolic Diseases Lipid Metabolism Disorders Gaucher Disease Revision: v2.9.1'. This change represents an update in the content related to Gaucher disease and additional resources available.
    Difference
    7%
    Check dated 2024-06-25T08:30:42.000Z thumbnail image

Stay in the know with updates to Velaglucerase Alfa for Type 1 Gaucher Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.